{"@id":"https://bioecon.ru/technology/macrophage-repolarization-therapy/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://bioecon.ru/technology/macrophage-repolarization-therapy/","json":"https://bioecon.ru/api/v1/technology/macrophage-repolarization-therapy/index.json"},"id":"macrophage-repolarization-therapy","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/united-therapeutics/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/anft-association-of-nature-forest-therapy/","https://bioecon.ru/companies/retro-biosciences/","https://bioecon.ru/companies/biohaven/"]},"maturity":7,"name":"Терапия реполяризации опухолеассоциированных макрофагов","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Валидация фенотипических мишеней"},{"n":2,"title":"Разработка модуляторов"},{"n":3,"title":"Тесты фагоцитоза"},{"n":4,"title":"Ремоделирование микросреды"}],"summary":"Таргетные препараты, перепрограммирующие иммуносупрессивные M2-макрофаги опухоли в провоспалительные M1-эффекторы, активно фагоцитирующие раковые клетки.","url":"/technology/macrophage-repolarization-therapy/","verified":"2026-11-22"}